Literature DB >> 12576607

Opportunistic screening for genital chlamydial infection. I: acceptability of urine testing in primary and secondary healthcare settings.

J M Pimenta1, M Catchpole, P A Rogers, E Perkins, N Jackson, C Carlisle, S Randall, J Hopwood, G Hewitt, G Underhill, H Mallinson, L McLean, T Gleave, J Tobin, V Harindra, A Ghosh.   

Abstract

OBJECTIVES: To determine the acceptability of opportunistic screening for Chlamydia trachomatis in young people in a range of healthcare settings.
DESIGN: An opportunistic screening programme (1 September 1999 to 31 August 2000) using urine samples tested by ligase chain reaction (LCR). Data on uptake and testing were collected and in-depth interviews were used for programme evaluation.
SETTING: General practice, family planning, genitourinary medicine clinics, adolescent sexual health clinics, termination of pregnancy clinics, and women's services in hospitals (antenatal, colposcopy, gynaecology and infertility clinics) in two health authorities (Wirral and Portsmouth and South East Hampshire). Main participants: Sexually active women aged between 16 and 24 years attending healthcare settings for any reason. MAIN OUTCOME MEASURES: Uptake data: proportion of women accepting a test by area, healthcare setting, and age; overall population coverage achieved in 1 year. Evaluation data: participants' attitudes and views towards opportunistic screening and urine testing.
RESULTS: Acceptance of testing by women (16-24 years) was 76% in Portsmouth and 84% in Wirral. Acceptance was lower in younger women (Portsmouth only) and varied by healthcare setting within each site. 50% of the target female population were screened in Portsmouth and 39% in Wirral. Both the opportunistic offer of screening and the method of screening were universally acceptable. Major factors influencing a decision to accept screening were the non-invasive nature of testing and treatment, desire to protect future fertility, and the experimental nature of the screening programme.
CONCLUSIONS: An opportunistic model of urine screening for chlamydial infection is a practical, universally acceptable method of screening.

Entities:  

Mesh:

Year:  2003        PMID: 12576607      PMCID: PMC1744586          DOI: 10.1136/sti.79.1.16

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  12 in total

1.  Screening for cervical chlamydial infection in general practice.

Authors:  P Oakeshott
Journal:  Br J Gen Pract       Date:  1999-11       Impact factor: 5.386

2.  Opportunistic screening for chlamydia infection in general practice: can we reach young women?

Authors:  M Santer; P Warner; S Wyke; S Sutherland
Journal:  J Med Screen       Date:  2000       Impact factor: 2.136

Review 3.  Evidence based case report: chlamydia infection in general practice.

Authors:  N R Hicks; M Dawes; M Fleminger; D Goldman; J Hamling; L J Hicks
Journal:  BMJ       Date:  1999-03-20

4.  Chlamydia trachomatis: opportunistic screening in primary care.

Authors:  C Tobin; R Aggarwal; J Clarke; R Chown; D King
Journal:  Br J Gen Pract       Date:  2001-07       Impact factor: 5.386

5.  Evaluation of self-taken samples for the presence of genital Chlamydia trachomatis infection in women using the ligase chain reaction assay.

Authors:  C Carder; A J Robinson; C Broughton; J M Stephenson; G L Ridgway
Journal:  Int J STD AIDS       Date:  1999-12       Impact factor: 1.359

6.  Efficacy of home sampling for screening of Chlamydia trachomatis: randomised study.

Authors:  L Ostergaard; B Andersen; F Olesen; J K Moller
Journal:  BMJ       Date:  1998-07-04

7.  Low diagnostic accuracy of selective screening criteria for asymptomatic Chlamydia trachomatis infections in the general population.

Authors:  I G van Valkengoed; S A Morré; A J van den Brule; C J Meijer; W Devillé; L M Bouter; A J Boeke
Journal:  Sex Transm Infect       Date:  2000-10       Impact factor: 3.519

8.  Home screening for chlamydial genital infection: is it acceptable to young men and women?

Authors:  J Stephenson; C Carder; A Copas; A Robinson; G Ridgway; A Haines
Journal:  Sex Transm Infect       Date:  2000-02       Impact factor: 3.519

9.  Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin.

Authors:  D G Addiss; M L Vaughn; D Ludka; J Pfister; J P Davis
Journal:  Sex Transm Dis       Date:  1993 Jan-Feb       Impact factor: 2.830

10.  A retrospective study of efforts to diagnose infections by Chlamydia trachomatis in a Swedish county.

Authors:  B F Herrmann; A B Johansson; P A Mårdh
Journal:  Sex Transm Dis       Date:  1991 Oct-Dec       Impact factor: 2.830

View more
  37 in total

1.  Modelling the healthcare costs of an opportunistic chlamydia screening programme.

Authors:  E J Adams; D S LaMontagne; A R Johnston; J M Pimenta; K A Fenton; W J Edmunds
Journal:  Sex Transm Infect       Date:  2004-10       Impact factor: 3.519

Review 2.  Best practice in primary care pathology: review 4.

Authors:  W S A Smellie; J Forth; S Sundar; E Kalu; C A M McNulty; E Sherriff; I D Watson; C Croucher; T M Reynolds; P J Carey
Journal:  J Clin Pathol       Date:  2006-05-19       Impact factor: 3.411

3.  The significance of voiding interval before testing urine samples for Chlamydia trachomatis in men.

Authors:  K Manavi; H Young
Journal:  Sex Transm Infect       Date:  2006-02       Impact factor: 3.519

4.  Diagnosis and treatment of presumed STIs at Mexican pharmacies: survey results from a random sample of Mexico City pharmacy attendants.

Authors:  A N Turner; C Ellertson; S Thomas; S García
Journal:  Sex Transm Infect       Date:  2003-06       Impact factor: 3.519

5.  Opportunistic screening for genital chlamydial infection. II: prevalence among healthcare attenders, outcome, and evaluation of positive cases.

Authors:  J M Pimenta; M Catchpole; P A Rogers; J Hopwood; S Randall; H Mallinson; E Perkins; N Jackson; C Carlisle; G Hewitt; G Underhill; T Gleave; L McLean; A Ghosh; J Tobin; V Harindra
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

6.  Incentive payments to general practitioners aimed at increasing opportunistic testing of young women for chlamydia: a pilot cluster randomised controlled trial.

Authors:  Jade E Bilardi; Christopher K Fairley; Meredith J Temple-Smith; Marie V Pirotta; Kathleen M McNamee; Siobhan Bourke; Lyle C Gurrin; Margaret Hellard; Lena A Sanci; Michelle J Wills; Jennifer Walker; Marcus Y Chen; Jane S Hocking
Journal:  BMC Public Health       Date:  2010-02-17       Impact factor: 3.295

7.  Testing for sexually transmitted infections in general practice: cross-sectional study.

Authors:  Katharine E Sadler; Nicola Low; Catherine H Mercer; Lorna J Sutcliffe; M Amir Islam; Shuja Shafi; Gary M Brook; Helen Maguire; Patrick J Horner; Jackie A Cassell
Journal:  BMC Public Health       Date:  2010-11-03       Impact factor: 3.295

8.  Young women's decisions to accept chlamydia screening: influences of stigma and doctor-patient interactions.

Authors:  Myles Balfe; Ruairi Brugha; Diarmuid O'Donovan; Emer O'Connell; Deirdre Vaughan
Journal:  BMC Public Health       Date:  2010-07-19       Impact factor: 3.295

9.  Demographics, sexual risk behaviours and uptake of screening for sexually transmitted infections among attendees of a weekly women-only community clinic program.

Authors:  Melanie L A Rusch; Jean A Shoveller; Susan Burgess; Karen Stancer; David M Patrick; Mark W Tyndall
Journal:  Can J Public Health       Date:  2008 Jul-Aug

10.  Delivery of chlamydia screening to young women requesting emergency hormonal contraception at pharmacies in Manchester, UK: a prospective study.

Authors:  Loretta Brabin; Grace Thomas; Mark Hopkins; Karen O'Brien; Stephen A Roberts
Journal:  BMC Womens Health       Date:  2009-03-26       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.